XWELL (XWEL)
Market Price (1/29/2026): $0.31 | Market Cap: $1.8 MilSector: Health Care | Industry: Life Sciences Tools & Services
XWELL (XWEL)
Market Price (1/29/2026): $0.31Market Cap: $1.8 MilSector: Health CareIndustry: Life Sciences Tools & Services
Investment Highlights Why It Matters Detailed financial logic regarding cash flow yields vs trend-riding momentum.
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -64% | Weak multi-year price returns2Y Excs Rtn is -121%, 3Y Excs Rtn is -169% | Penny stockMkt Price is 0.3 |
| Megatrend and thematic driversMegatrends include Experience Economy & Premiumization, and Health & Wellness Trends. Themes include Experiential Retail, and Traveler Wellness Services. | Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -10 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -34% | |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 289% | ||
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -13%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -21%, Rev Chg QQuarterly Revenue Change % is -13% | ||
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -41%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -51% | ||
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -834% | ||
| Key risksXWEL key risks include [1] substantial doubt about its ability to continue as a going concern, Show more. |
| Valuation becoming less expensiveP/S 6M Chg %Price/Sales change over 6 months. Declining P/S indicates valuation has become less expensive. is -64% |
| Megatrend and thematic driversMegatrends include Experience Economy & Premiumization, and Health & Wellness Trends. Themes include Experiential Retail, and Traveler Wellness Services. |
| Weak multi-year price returns2Y Excs Rtn is -121%, 3Y Excs Rtn is -169% |
| Penny stockMkt Price is 0.3 |
| Not profitable at operating income levelOp Inc LTMOperating Income, Last Twelve Months is -10 Mil, Op Mgn LTMOperating Margin = Operating Income / Revenue Reflects profitability before taxes and before impact of capital structure (interest payments). is -34% |
| Debt is significantNet D/ENet Debt/Equity. Debt net of cash. Negative indicates net cash. Equity is taken as the Market Capitalization is 289% |
| Weak revenue growthRev Chg LTMRevenue Change % Last Twelve Months (LTM) is -13%, Rev Chg 3Y AvgRevenue Change % averaged over trailing 3 years is -21%, Rev Chg QQuarterly Revenue Change % is -13% |
| Not cash flow generativeCFO/Rev LTMCash Flow from Operations / Revenue (Sales), Last Twelve Months (LTM) is -41%, FCF/Rev LTMFree Cash Flow / Revenue (Sales), Last Twelve Months (LTM) is -51% |
| Yield minus risk free rate is negativeERPEquity Risk Premium (ERP) = Total Yield - Risk Free Rate, Reflects the premium above risk free assets offered by the investment. is -834% |
| Key risksXWEL key risks include [1] substantial doubt about its ability to continue as a going concern, Show more. |
Qualitative Assessment
AI Analysis | Feedback
XWELL (XWEL) stock has lost about 65% since 9/30/2025 because of the following key factors:
1. Nasdaq Minimum Bid Price Deficiency and Authorization for Reverse Stock Split
XWELL received a notification from Nasdaq due to its common stock failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days. The company was granted a compliance period until June 1, 2026, to regain compliance. In response to this, shareholders approved an amendment to the company's Certificate of Incorporation, granting the board authority to implement a reverse stock split at a ratio between 1-for-2 and 1-for-20. Such actions often signal underlying financial difficulties and can lead to a further decrease in investor confidence and stock value.
2. Continued Operating Losses and Unprofitability
Despite reporting a revenue increase to $7.7 million in Q2 2025 from $7.0 million in the previous quarter, XWELL experienced an operating loss of $2.7 million and a net loss of $2.3 million. For the trailing 12 months ending September 30, 2025, Xwell's earnings totaled -$17.4 million, and for the fiscal year 2024, losses were -$16.85 million. This sustained trend of unprofitability and ongoing losses significantly contributed to the decline in the company's stock price as investors became wary of its financial viability.
Show more
1. Nasdaq Minimum Bid Price Deficiency and Authorization for Reverse Stock Split
XWELL received a notification from Nasdaq due to its common stock failing to meet the minimum $1.00 bid price requirement for 30 consecutive business days. The company was granted a compliance period until June 1, 2026, to regain compliance. In response to this, shareholders approved an amendment to the company's Certificate of Incorporation, granting the board authority to implement a reverse stock split at a ratio between 1-for-2 and 1-for-20. Such actions often signal underlying financial difficulties and can lead to a further decrease in investor confidence and stock value.
2. Continued Operating Losses and Unprofitability
Despite reporting a revenue increase to $7.7 million in Q2 2025 from $7.0 million in the previous quarter, XWELL experienced an operating loss of $2.7 million and a net loss of $2.3 million. For the trailing 12 months ending September 30, 2025, Xwell's earnings totaled -$17.4 million, and for the fiscal year 2024, losses were -$16.85 million. This sustained trend of unprofitability and ongoing losses significantly contributed to the decline in the company's stock price as investors became wary of its financial viability.
Show more
Stock Movement Drivers
Fundamental Drivers
The -67.3% change in XWEL stock from 9/30/2025 to 1/28/2026 was primarily driven by a -63.9% change in the company's P/S Multiple.| (LTM values as of) | 9302025 | 1282026 | Change |
|---|---|---|---|
| Stock Price ($) | 0.99 | 0.32 | -67.3% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 31 | 30 | -3.5% |
| P/S Multiple | 0.2 | 0.1 | -63.9% |
| Shares Outstanding (Mil) | 5 | 6 | -6.0% |
| Cumulative Contribution | -67.3% |
Market Drivers
9/30/2025 to 1/28/2026| Return | Correlation | |
|---|---|---|
| XWEL | -67.3% | |
| Market (SPY) | 4.4% | 15.5% |
| Sector (XLV) | 10.9% | 22.3% |
Fundamental Drivers
The -64.9% change in XWEL stock from 6/30/2025 to 1/28/2026 was primarily driven by a -58.0% change in the company's P/S Multiple.| (LTM values as of) | 6302025 | 1282026 | Change |
|---|---|---|---|
| Stock Price ($) | 0.92 | 0.32 | -64.9% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 32 | 30 | -8.3% |
| P/S Multiple | 0.2 | 0.1 | -58.0% |
| Shares Outstanding (Mil) | 5 | 6 | -8.7% |
| Cumulative Contribution | -64.9% |
Market Drivers
6/30/2025 to 1/28/2026| Return | Correlation | |
|---|---|---|
| XWEL | -64.9% | |
| Market (SPY) | 12.9% | 19.6% |
| Sector (XLV) | 15.0% | 5.2% |
Fundamental Drivers
The -78.5% change in XWEL stock from 12/31/2024 to 1/28/2026 was primarily driven by a -70.6% change in the company's P/S Multiple.| (LTM values as of) | 12312024 | 1282026 | Change |
|---|---|---|---|
| Stock Price ($) | 1.51 | 0.32 | -78.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 34 | 30 | -12.7% |
| P/S Multiple | 0.2 | 0.1 | -70.6% |
| Shares Outstanding (Mil) | 5 | 6 | -16.4% |
| Cumulative Contribution | -78.5% |
Market Drivers
12/31/2024 to 1/28/2026| Return | Correlation | |
|---|---|---|
| XWEL | -78.5% | |
| Market (SPY) | 19.7% | -7.3% |
| Sector (XLV) | 13.7% | -8.7% |
Fundamental Drivers
The -95.5% change in XWEL stock from 12/31/2022 to 1/28/2026 was primarily driven by a -85.7% change in the company's P/S Multiple.| (LTM values as of) | 12312022 | 1282026 | Change |
|---|---|---|---|
| Stock Price ($) | 7.26 | 0.32 | -95.5% |
| Change Contribution By: | |||
| Total Revenues ($ Mil) | 78 | 30 | -62.0% |
| P/S Multiple | 0.4 | 0.1 | -85.7% |
| Shares Outstanding (Mil) | 5 | 6 | -17.9% |
| Cumulative Contribution | -95.5% |
Market Drivers
12/31/2022 to 1/28/2026| Return | Correlation | |
|---|---|---|
| XWEL | -95.5% | |
| Market (SPY) | 88.6% | 3.4% |
| Sector (XLV) | 18.9% | -3.3% |
Price Returns Compared
| 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | Total [1] | |
|---|---|---|---|---|---|---|---|
| Returns | |||||||
| XWEL Return | 70% | -82% | -76% | -13% | -69% | -30% | -99% |
| Peers Return | 4% | -15% | -8% | -24% | 35% | -1% | -16% |
| S&P 500 Return | 27% | -19% | 24% | 23% | 16% | 2% | 86% |
Monthly Win Rates [3] | |||||||
| XWEL Win Rate | 67% | 25% | 25% | 50% | 33% | 0% | |
| Peers Win Rate | 56% | 53% | 47% | 42% | 54% | 50% | |
| S&P 500 Win Rate | 75% | 42% | 67% | 75% | 67% | 100% | |
Max Drawdowns [4] | |||||||
| XWEL Max Drawdown | -13% | -83% | -80% | -27% | -69% | -30% | |
| Peers Max Drawdown | -20% | -41% | -42% | -35% | -19% | -8% | |
| S&P 500 Max Drawdown | -1% | -25% | -1% | -2% | -15% | -1% | |
[1] Cumulative total returns since the beginning of 2021
[2] Peers: A, ATEC, CERS, AVRT, BLLN.
[3] Win Rate = % of calendar months in which monthly returns were positive
[4] Max drawdown represents maximum peak-to-trough decline within a year
[5] 2026 data is for the year up to 1/28/2026 (YTD)
How Low Can It Go
| Event | XWEL | S&P 500 |
|---|---|---|
| 2022 Inflation Shock | ||
| % Loss | -97.4% | -25.4% |
| % Gain to Breakeven | 3803.4% | 34.1% |
| Time to Breakeven | Not Fully Recovered days | 464 days |
| 2020 Covid Pandemic | ||
| % Loss | -89.7% | -33.9% |
| % Gain to Breakeven | 868.8% | 51.3% |
| Time to Breakeven | 77 days | 148 days |
Compare to A, ATEC, CERS, AVRT, BLLN
In The Past
XWELL's stock fell -97.4% during the 2022 Inflation Shock from a high on 2/16/2021. A -97.4% loss requires a 3803.4% gain to breakeven.
Preserve Wealth
Limiting losses and compounding gains is essential to preserving wealth.
Asset Allocation
Actively managed asset allocation strategies protect wealth. Learn more.
About XWELL (XWEL)
XpresSpa Group, Inc., a health and wellness services company, provides spa services at airports. It operates through three segments: XpresSpa, XpresTest, and Treat. The company offers spa services, including massage, and nail and skin care, as well as spa and travel products; and retail products. It also operates wellness centers that provides COVID-19 screening and testing, and rapid testing services for other communicable diseases, such as influenza, COVID-19, RSV, Flu A&B, and seasonal flu vaccination services; and other medical diagnostic testing services. In addition, the company offers services through an integrated digital platform, and a relevant retail offering to the traveling public. As of December 31, 2021, it operated 52 spa and clinic locations in 24 airports in the United States, the Netherlands, and the United Arab Emirates. The company was formerly known as FORM Holdings Corp. and changed its name to XpresSpa Group, Inc. in January 2018. XpresSpa Group, Inc. is headquartered in New York, New York.
AI Analysis | Feedback
Here are 1-3 brief analogies for XWELL:
- CVS or Walgreens, but exclusively for health and wellness services found inside airports.
- Starbucks for airport spa and wellness services.
- MinuteClinic (CVS) for travelers.
AI Analysis | Feedback
- XpresSpa (Personal Wellness Services): Provides premium spa treatments, including massages, facials, manicures, and pedicures, primarily within airport terminals.
- XpresCheck (Travel Health Services): Offers accessible health diagnostic and screening services, initially focused on COVID-19 testing, at various airport locations.
- HyperPointe (Health Technology Solutions): Develops and deploys innovative technology platforms for health monitoring, patient engagement, and large-scale health program management.
AI Analysis | Feedback
XWELL (Symbol: XWEL) - Major Customers
XWELL primarily sells its health and wellness services directly to individuals, specifically travelers within airports. The company operates airport spas (XpresSpa), health and wellness centers (Treat), and historically, diagnostic testing facilities (XpresCheck). Below are the primary categories of individual customers it serves:
-
General Airport Travelers Seeking Relaxation and Grooming: This category encompasses both leisure and business travelers who utilize XWELL's XpresSpa locations. These customers seek traditional spa services such as massages, manicures, pedicures, and facials to relax, de-stress, and refresh themselves during their travel journeys.
-
Health-Conscious and Wellness-Seeking Travelers: This segment includes individuals who are proactive about their health and well-being, primarily utilizing XWELL's "Treat" brand. These customers seek services like IV vitamin therapy, cryotherapy, quick health consultations, and other holistic wellness treatments aimed at boosting immunity, combating travel fatigue, or maintaining overall vitality while on the go.
-
Travelers with On-Demand Health or Diagnostic Needs: While its XpresCheck operations for widespread diagnostic testing have largely scaled back post-pandemic, this category historically included travelers requiring immediate health screenings or testing for travel compliance or general health concerns. The "Treat" brand may still cater to some of these immediate, minor health needs, offering convenient access to quick health assessments or therapeutic interventions within the airport environment.
AI Analysis | Feedback
null
AI Analysis | Feedback
Ezra Ernst, Chief Executive Officer
Ezra Ernst was appointed CEO of XWELL in September 2024, having joined the company in 2022. He brings over 20 years of executive experience in the health, wellness, and biosecurity sectors, driving innovation, strategic growth, and global expansion. Before becoming CEO of XWELL, he served as CEO and Chief Commercial Officer at other leading wellness firms, where he developed scalable solutions. He also previously held the CEO position for XWELL brands XpresCheck and HyperPointe.
Ian Brown, Chief Financial Officer
Ian Brown became XWELL's CFO in January 2025. He possesses over 25 years of senior finance experience from various sectors, including startups, media, and consumer products. His expertise spans corporate finance, strategic planning, investor relations, and mergers and acquisitions. Prior to XWELL, Mr. Brown served as a managing director at Accordion's Strategic FP&A Group and held senior finance roles at companies such as FTI Consulting, Charter Communications, and Insight Communications.
Cara Soffer, General Counsel
Cara Soffer is a seasoned legal executive with 13 years of experience in both public and private health and wellness companies. Since 2021, she has served as General Counsel and Board Secretary for XWELL, where she is instrumental in shaping the company's legal strategy and ensuring compliance. Previously, she was the General Counsel for EXOS, a private global wellness company, providing legal guidance during periods of significant growth.
Patti Ward, VP of Biosecurity and Technology
Patti Ward is an accomplished product and technology leader with extensive expertise in the health and wellness industries. As Vice President of Biosecurity and Technology, she is responsible for driving innovation at the intersection of public health, wellness, and emerging technology, developing solutions that enhance global health security and operational effectiveness.
Marlene Albarano, General Manager, North America
Marlene Albarano joined XWELL in June 2024 as the General Manager for North America. She leads operations and strategic growth for the company's airport-based wellness locations, bringing over 20 years of experience in consumer services to enhance customer experience, streamline operations, and boost team performance.
AI Analysis | Feedback
The public company XWELL (symbol: XWEL) faces several significant risks to its business operations and financial viability. The most prominent risks include its ability to continue as a going concern, material weaknesses in internal controls over financial reporting, and the volatility of its stock price, coupled with the risk of delisting from Nasdaq.
- Ability to Continue as a Going Concern: XWELL's financial statements have been prepared on a going concern basis, indicating substantial doubt about its ability to continue operations due to recurring losses and insufficient liquidity. The company has reported significant operating and net losses in recent periods, and there is a recognized need to raise additional capital to fund operations. However, raising such capital may be challenging given its low stock price and could lead to dilution for existing shareholders.
- Material Weaknesses in Internal Controls Over Financial Reporting: XWELL has identified material weaknesses in its internal controls over financial reporting. If these weaknesses are not remediated, they could impair the company's ability to produce accurate consolidated financial statements on a timely basis, potentially resulting in material misstatements and eroding investor confidence.
- Stock Price Volatility and Potential Delisting: The company's stock has experienced a precipitous decline in shareholder value, with its stock plummeting significantly over recent years. There is a risk that XWELL may fail to meet the continued listing requirements of Nasdaq, which could result in its common stock being delisted. Delisting would adversely affect the company's ability to raise additional financing, significantly impact investors' ability to trade its securities, and negatively affect the value and liquidity of its common stock.
AI Analysis | Feedback
The expansion of premium airport lounges to include more extensive wellness services, such as advanced relaxation areas, massage services, and tranquil zones, poses an emerging threat. As a growing segment of travelers gains access to these upgraded lounges through airline status or premium credit card benefits, they may increasingly opt for these inclusive amenities as part of their lounge experience, thereby reducing their incentive to pay separately for XWELL's XpresSpa services. This trend could gradually erode XpresSpa's addressable market and customer base as the "bundled" lounge experience becomes a more attractive and comprehensive wellness solution within airports.
AI Analysis | Feedback
XWELL (Nasdaq: XWEL) operates across several segments in the health and wellness industry. The addressable markets for its main products and services are as follows: * Spa Services (XpresSpa, Treat): The global spa services market was valued at $73.51 billion in 2020 and is projected to reach $423.25 billion by 2031, growing at a compound annual growth rate (CAGR) of 17.3% from 2022 to 2031. More broadly, the global spa market size was valued at $61.68 billion in 2024 and is expected to reach $146.95 billion by 2033, exhibiting a CAGR of 9.62% during 2025-2033. North America is a significant region within this market, holding an estimated share of 36.1% in 2025. * Wellness Tourism (XpresSpa, Treat): The global wellness tourism market was estimated at $814.6 billion in 2022 and is projected to reach $2,096.3 billion by 2030, growing at a CAGR of 12.5% from 2023 to 2030. North America represented the largest revenue-generating market in this sector in 2022. Another report estimates the wellness tourism market size at $915.77 billion in 2023, poised to grow to $2,622.31 billion by 2032, with a CAGR of 12.4% during 2025-2032. * Biosurveillance Monitoring (XpresCheck): The global airport health passport market, which includes digital health verification systems, reached $1.8 billion in 2024 and is expected to grow to approximately $8.5 billion by 2033, at a CAGR of 16.5%. * Medical Spas (Planned Acquisitions): XWELL is expanding into the medical spa sector, which is part of the broader aesthetics market, valued at $68 billion. * Travel Retail (Wellness Products at Airports): The global travel retail market size was valued at $79.93 billion in 2024 and is expected to reach $229.45 billion by 2032, at a CAGR of 14.09% during the forecast period. The airport segment dominated this market in 2024 due to high passenger volumes.AI Analysis | Feedback
Here are 3-5 expected drivers of future revenue growth for XWELL (symbol: XWEL) over the next 2-3 years:
- Expansion into the out-of-airport wellness and beauty sector: XWELL is strategically expanding beyond airport locations into the broader wellness and beauty market. This includes plans to acquire select medical spas during 2025 in high-demand metropolitan areas such as Orlando, Austin, and Salt Lake City, leveraging a $4 million private placement. The MedSpa industry is projected for significant growth, with a compound annual growth rate exceeding 15% and an expected total addressable market of over $49 billion by 2030. Additionally, the company launched a new Naples Wax Center in Estero, Florida in December 2024 and aims to open six more locations across Florida in 2025.
- Broadening of the retail product portfolio: XWELL is actively expanding its retail product offerings to include cutting-edge wellness products. These new offerings are designed to feature state-of-the-art wellness devices, nutritional supplements, and innovative wellness patches, catering to the evolving needs of health-conscious consumers.
- Continued growth of the Traveler-based Genomic Surveillance Program (TGS) and HyperPointe business: XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program with the CDC in March 2025, which provides early detection of emerging pathogens through airport-based biosurveillance. The company continues to operate its XpresCheck and HyperPointe units, which are at the forefront of biosurveillance and digital healthcare infrastructure, with HyperPointe supporting providers and patients through BioPharma partnerships.
- Strategic partnerships and loyalty programs: XWELL is focusing on enhancing customer engagement and expanding access through strategic partnerships and loyalty programs. The company expanded its partnership with Priority Pass, a global airport experiences program, to enable seamless access to XWELL locations and foster deeper customer relationships. Furthermore, XWELL was named the official wellness spa of the Orlando Magic in June 2025 through a multiyear partnership, marking a significant entry into local markets, starting with Florida.
- Unification of wellness offerings under a single XWELL brand identity: As part of its brand evolution, XWELL plans to unite all of its diverse wellness offerings under a single, cohesive XWELL brand identity. This strategy aims to enhance brand recognition, improve customer experience, and drive growth in the rapidly expanding wellness market by integrating its services and fostering greater customer loyalty.
AI Analysis | Feedback
Share Repurchases
- XWELL's board of directors authorized a stock repurchase program on August 31, 2021, permitting the purchase of up to 15 million shares of its common stock.
- In May 2022, the board increased the share repurchase program by an additional 10 million shares and extended its effectiveness through September 15, 2023.
- Under this program, XWELL repurchased and retired 19.5 million shares at an average cost of $1.22 per share, totaling $23.8 million.
Share Issuance
- A 1-for-20 reverse stock split was effected on September 28, 2023.
- In January 2025, the company closed a $4.0 million private placement offering of newly designated Series G Convertible Preferred Stock, accompanied by the issuance of Series A and Series B warrants.
- In November 2025, XWELL agreed to exchange Series G preferred stock with a stated value of $1.55 million for senior secured convertible notes with a principal of $3.39 million, initially convertible at $1.00 per share.
Inbound Investments
- In March 2025, XWELL secured a three-year extension of its Traveler-based Genomic Surveillance Program with the CDC and Ginkgo Bioworks, with a total base value of $53.7 million and a maximum ceiling of $85.7 million.
- The CDC program, in collaboration with Concentric by Ginkgo BioWorks, was extended in January 2022 for a total contract of $5.537 million, renewed in August 2022 for approximately $7.330 million (first year revenue), and renewed again in August 2023 for approximately $7.044 million in revenue, with a $4.0 million expansion in March 2024.
- XWELL successfully closed a $4.0 million private placement in January 2025 through the issuance of convertible preferred stock and warrants.
Outbound Investments
- In 2022, XWELL issued $906 thousand (in thousands) of common stock in connection with the acquisition of gcg Connect, LLC, operating as HyperPointe.
- In March 2025, XWELL unveiled plans to acquire select medical spas during 2025, leveraging its recent $4 million private placement to expand into the wellness and beauty sector.
Capital Expenditures
- Capital expenditures were reported as $544 thousand in 2022 and $17 thousand in 2023, primarily allocated to leasehold improvements, furniture and fixtures, and other operating equipment.
- The company's business requires substantial capital expenditures for the development of new branding concepts in the travel health and wellness space, and for maintaining and expanding operations in existing and new locations, as well as technology costs and compliance.
- XWELL opened new locations including a Naples Wax Center in Estero, Florida in December 2024, and the Waterford Lakes Wellness Center and Bloomingdale Wellness Center in September 2025, as part of its expansion efforts.
Latest Trefis Analyses
| Title | Date | |
|---|---|---|
| DASHBOARDS | ||
| XWELL Earnings Notes | 12/16/2025 | |
| Would You Still Hold XWELL Stock If It Fell Another 30%? | 10/17/2025 |
| Title | |
|---|---|
| ARTICLES |
Research & Analysis
Invest in Strategies
Wealth Management
Peer Comparisons
| Peers to compare with: |
Financials
| Median | |
|---|---|
| Name | |
| Mkt Price | 15.26 |
| Mkt Cap | 2.3 |
| Rev LTM | 464 |
| Op Inc LTM | -10 |
| FCF LTM | -2 |
| FCF 3Y Avg | -16 |
| CFO LTM | 19 |
| CFO 3Y Avg | -13 |
Growth & Margins
| Median | |
|---|---|
| Name | |
| Rev Chg LTM | 9.9% |
| Rev Chg 3Y Avg | 4.5% |
| Rev Chg Q | 12.0% |
| QoQ Delta Rev Chg LTM | 2.9% |
| Op Mgn LTM | -7.4% |
| Op Mgn 3Y Avg | -16.8% |
| QoQ Delta Op Mgn LTM | 2.6% |
| CFO/Rev LTM | 3.3% |
| CFO/Rev 3Y Avg | -7.6% |
| FCF/Rev LTM | -0.2% |
| FCF/Rev 3Y Avg | -15.7% |
Valuation
| Median | |
|---|---|
| Name | |
| Mkt Cap | 2.3 |
| P/S | 2.7 |
| P/EBIT | -10.2 |
| P/E | -7.5 |
| P/CFO | 45.0 |
| Total Yield | -5.1% |
| Dividend Yield | 0.0% |
| FCF Yield 3Y Avg | -5.9% |
| D/E | 0.2 |
| Net D/E | 0.0 |
Returns
| Median | |
|---|---|
| Name | |
| 1M Rtn | -2.8% |
| 3M Rtn | -7.5% |
| 6M Rtn | 13.8% |
| 12M Rtn | -10.2% |
| 3Y Rtn | -21.0% |
| 1M Excs Rtn | -4.3% |
| 3M Excs Rtn | -10.0% |
| 6M Excs Rtn | 2.6% |
| 12M Excs Rtn | -26.7% |
| 3Y Excs Rtn | -94.6% |
Price Behavior
Price Behavior
| Market Price | $0.32 | |
| Market Cap ($ Bil) | 0.0 | |
| First Trading Date | 07/27/2010 | |
| Distance from 52W High | -75.5% | |
| 50 Days | 200 Days | |
| DMA Price | $0.62 | $0.89 |
| DMA Trend | down | down |
| Distance from DMA | -47.4% | -63.6% |
| 3M | 1YR | |
| Volatility | 81.1% | 74.5% |
| Downside Capture | 369.20 | 102.16 |
| Upside Capture | -273.75 | -49.06 |
| Correlation (SPY) | 14.7% | -8.4% |
XWEL Betas & Captures as of 12/31/2025
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
| 1M | 2M | 3M | 6M | 1Y | 3Y | |
|---|---|---|---|---|---|---|
| Beta | 0.74 | 0.74 | 0.68 | 1.22 | -0.33 | 0.16 |
| Up Beta | -4.45 | 0.85 | 1.30 | 1.14 | -1.05 | -0.59 |
| Down Beta | -2.06 | -0.47 | 0.32 | 0.84 | -0.44 | 0.04 |
| Up Capture | -265% | -155% | -116% | 14% | -12% | 1% |
| Bmk +ve Days | 11 | 23 | 37 | 72 | 143 | 431 |
| Stock +ve Days | 5 | 13 | 23 | 51 | 102 | 308 |
| Down Capture | 677% | 311% | 228% | 218% | 109% | 106% |
| Bmk -ve Days | 11 | 18 | 27 | 55 | 108 | 320 |
| Stock -ve Days | 14 | 25 | 38 | 72 | 139 | 406 |
[1] Upside and downside betas calculated using positive and negative benchmark daily returns respectively
Based On 1-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with XWEL | |
|---|---|---|---|---|
| XWEL | -72.7% | 74.4% | -1.43 | - |
| Sector ETF (XLV) | 6.0% | 17.2% | 0.18 | -9.2% |
| Equity (SPY) | 17.1% | 19.3% | 0.69 | -8.6% |
| Gold (GLD) | 97.2% | 20.8% | 3.18 | 3.4% |
| Commodities (DBC) | 13.8% | 15.4% | 0.64 | -1.5% |
| Real Estate (VNQ) | 1.2% | 16.5% | -0.10 | -8.4% |
| Bitcoin (BTCUSD) | -12.7% | 39.6% | -0.25 | 1.8% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 5-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with XWEL | |
|---|---|---|---|---|
| XWEL | -59.8% | 82.4% | -0.75 | - |
| Sector ETF (XLV) | 7.1% | 14.5% | 0.31 | 3.6% |
| Equity (SPY) | 14.1% | 17.1% | 0.66 | 12.5% |
| Gold (GLD) | 23.2% | 15.8% | 1.19 | 3.7% |
| Commodities (DBC) | 12.6% | 18.8% | 0.54 | 1.3% |
| Real Estate (VNQ) | 4.7% | 18.8% | 0.16 | 12.1% |
| Bitcoin (BTCUSD) | 23.7% | 57.6% | 0.60 | 6.3% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Based On 10-Year Data
| Annualized Return | Annualized Volatility | Sharpe Ratio | Correlation with XWEL | |
|---|---|---|---|---|
| XWEL | -58.0% | 114.3% | -0.43 | - |
| Sector ETF (XLV) | 10.5% | 16.6% | 0.52 | 9.5% |
| Equity (SPY) | 16.0% | 17.9% | 0.77 | 15.5% |
| Gold (GLD) | 16.8% | 14.9% | 0.94 | 2.3% |
| Commodities (DBC) | 9.2% | 17.6% | 0.43 | 9.0% |
| Real Estate (VNQ) | 6.1% | 20.8% | 0.26 | 16.8% |
| Bitcoin (BTCUSD) | 70.9% | 66.5% | 1.10 | 6.5% |
Smart multi-asset allocation framework can stack odds in your favor. Learn How
Returns Analyses
Earnings Returns History
Expand for More| Forward Returns | |||
|---|---|---|---|
| Earnings Date | 1D Returns | 5D Returns | 21D Returns |
| 11/14/2025 | 11.8% | -9.7% | -12.5% |
| 8/14/2025 | -5.8% | -10.0% | -10.0% |
| 4/15/2025 | -0.3% | 2.4% | 23.7% |
| 11/14/2024 | -1.5% | -13.9% | 11.9% |
| 8/14/2024 | 1.0% | -5.7% | -17.9% |
| 4/16/2024 | 1.5% | 3.6% | 34.3% |
| 11/14/2023 | -4.1% | 17.0% | 23.4% |
| 8/14/2023 | -10.9% | -2.2% | -21.1% |
| ... | |||
| SUMMARY STATS | |||
| # Positive | 6 | 4 | 8 |
| # Negative | 12 | 14 | 10 |
| Median Positive | 5.9% | 10.3% | 15.2% |
| Median Negative | -5.5% | -9.9% | -21.4% |
| Max Positive | 14.6% | 34.9% | 34.3% |
| Max Negative | -14.0% | -26.3% | -83.1% |
SEC Filings
Expand for More| Report Date | Filing Date | Filing |
|---|---|---|
| 09/30/2025 | 11/14/2025 | 10-Q |
| 06/30/2025 | 08/14/2025 | 10-Q |
| 03/31/2025 | 05/20/2025 | 10-Q |
| 12/31/2024 | 04/15/2025 | 10-K |
| 09/30/2024 | 11/14/2024 | 10-Q |
| 06/30/2024 | 08/14/2024 | 10-Q |
| 03/31/2024 | 05/15/2024 | 10-Q |
| 12/31/2023 | 04/16/2024 | 10-K |
| 09/30/2023 | 11/14/2023 | 10-Q |
| 06/30/2023 | 08/14/2023 | 10-Q |
| 03/31/2023 | 05/15/2023 | 10-Q |
| 12/31/2022 | 04/17/2023 | 10-K |
| 09/30/2022 | 11/14/2022 | 10-Q |
| 06/30/2022 | 08/15/2022 | 10-Q |
| 03/31/2022 | 05/16/2022 | 10-Q |
| 12/31/2021 | 03/31/2022 | 10-K |
External Quote Links
| Y Finance | Barrons |
| TradingView | Morningstar |
| SeekingAlpha | ValueLine |
| Motley Fool | Robinhood |
| CNBC | Etrade |
| MarketWatch | Unusual Whales |
| YCharts | Perplexity Finance |
| FinViz |
Prefer one of these to Trefis? Tell us why.